Ikena Oncology, Inc. (IKNA): Price and Financial Metrics

Ikena Oncology, Inc. (IKNA): $1.71

0.03 (-1.72%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add IKNA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#97 of 333

in industry

IKNA Price/Volume Stats

Current price $1.71 52-week high $2.32
Prev. close $1.74 52-week low $1.22
Day low $1.70 Volume 9,648
Day high $1.73 Avg. volume 244,357
50-day MA $1.71 Dividend yield N/A
200-day MA $1.57 Market Cap 82.52M

IKNA Stock Price Chart Interactive Chart >


Ikena Oncology, Inc. (IKNA) Company Bio


Ikena Oncology, Inc., a targeted oncology company, focuses on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, a selective AHR antagonist; IK-412, a recombinant human kynurenine-degrading enzyme; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.


IKNA Latest News Stream


Event/Time News Detail
Loading, please wait...

IKNA Latest Social Stream


Loading social stream, please wait...

View Full IKNA Social Stream

IKNA Price Returns

1-mo 0.00%
3-mo 0.00%
6-mo 19.58%
1-year 22.14%
3-year -89.44%
5-year N/A
YTD -13.20%
2023 -25.94%
2022 -78.79%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!